Ajanta Pharma Ltd. Conference Calls and Earnings Call Transcripts

22 Jul 2021

2586.40

1.06%

Earnings Call

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements ) Regulations 2015, we are enclosing herewith the schedule of Earnings conference call to be held on 29th July 2021, post Board meeting. This is for your information and records please.

pdf

Ajanta Pharma Ltd.

04 May 2021, 02:24PM

2586.40

1.06%

Earnings Call

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Further to our communication dated 30th April 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 30th April 2021 at 5.30 p.m. has been uploaded on the Company's website and can be accessed through the link http://ajantapharma.com/Results.aspx This is for your information and records please.

pdf

Ajanta Pharma Ltd.

30 Apr 2021

2586.40

1.06%

Earnings Call

Ajanta Pharma Ltd - 532331 - Audio Recording Of Earnings Call Conducted On 30Th April 2021

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 30th April 2021 at 5.30 p.m. has been uploaded on the Company's website and can be accessed through the link http://ajantapharma.com/Results.aspx Written transcript of the same will be submitted in due course. This is for your information and records please.

pdf

Ajanta Pharma Ltd.

30 Apr 2021

2586.40

1.06%

Earnings Call for Q4FY21 of Ajanta Pharma

Conference Call with Ajanta Pharma Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.

Ajanta Pharma Ltd. Conference Calls and Earnings Call Transcripts